Nihon Kohden (OTCMKTS:NHNKY) Issues Earnings Results, Misses Estimates By $0.09 EPS

Nihon Kohden (OTCMKTS:NHNKY) posted its quarterly earnings results on Thursday. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.09), Zacks reports. Nihon Kohden had a return on equity of 9.46% and a net margin of 6.08%.The firm had revenue of $297.47 million for the quarter, compared to the consensus estimate of $299.98 million.

Nihon Kohden Stock Down 2.6%

Shares of OTCMKTS NHNKY traded down $0.24 during midday trading on Friday, reaching $9.10. 4,757 shares of the company were exchanged, compared to its average volume of 27,381. The stock has a market cap of $1.53 billion, a P/E ratio of 15.42 and a beta of 0.37. Nihon Kohden has a one year low of $8.12 and a one year high of $14.21. The stock’s 50-day moving average price is $9.12 and its 200-day moving average price is $9.76.

Analyst Ratings Changes

Separately, Zacks Research raised shares of Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, Nihon Kohden presently has a consensus rating of “Buy”.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.